Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study
employers_2024
1 other identifier
observational
30
1 country
1
Brief Summary
European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work reintegration. In Italy there is lack of knowledge regarding this topic. Thus, further exploration of Italian employers' perspectives on the RTW of employees with cancer should be performed to comprehend their unknown experiences. The aim is to explore the perspectives of employers who dealt with the RTW process of employees who received a cancer diagnosis through a qualitative research design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
August 29, 2025
August 1, 2025
1.2 years
May 20, 2025
August 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
1. Open-ended questions of a semi-structured interview to collect the employers experience of the management of the RTW process
Themes describing how employers managed the RTW process of employees with cancer, of their feeling and thoughts, of what actions did they do, and of the relationships and communication with the other members of the company
12 months
Open-ended questions of a semi-structured interview to collect the employers' necessities while supporting the RTW process
Themes describing what employers require to support employees who receive a cancer diagnosis in the RTW process
12 months
Open-ended questions of a semi-structured interview to collect the employers perceived barriers and facilitators while supporting the RTW process
Themes describing the facilitators and barriers perceived by employers during the RTW process of employees who received a cancer diagnosis. For this outcome, themes will be classified using the Resource Dependence Institutional Cooperation (RDIC) model, developed by Rijk et al. and adjusted by Greidanus et al. (2018).
12 months
Study Arms (1)
Employers
This cohort includes employers of active companies located in the province of Reggio Emilia. The Chamber of Commerce dell 'Emilia will provide a random list of the active company based on the type of company (profit, non-for-profit), type of sector (i.e., manufacturing, constructions), and number of employees (small, medium, large) to guarantee the representativeness of our context.
Eligibility Criteria
The study population consists of employers of the province of Reggio Emilia who managed the RTW process of employees with a cancer diagnosis. This population includes employers from companies with diverse characteristics (type of company and sector, and number of employees) to collect the perspectives of employers working in different settings.
You may qualify if:
- employers\* of a company
- being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years.
- An employer can be the specific person who represents the company where the employee was working at the time of cancer diagnosis or a person who supported the employee during the sickness absence and the RTW process (e.g., line manager, human resource manager).
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, RE, 42123, Italy
Related Publications (5)
Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterle B, Frings-Dresen MHW, Tamminga SJ. Perceived employer-related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectives. Psychooncology. 2018 Mar;27(3):725-733. doi: 10.1002/pon.4514. Epub 2017 Sep 6.
PMID: 28753741BACKGROUNDLawler M, De Lorenzo F, Lagergren P, Mennini FS, Narbutas S, Scocca G, Meunier F; European Academy of Cancer Sciences. Challenges and solutions to embed cancer survivorship research and innovation within the EU Cancer Mission. Mol Oncol. 2021 Jul;15(7):1750-1758. doi: 10.1002/1878-0261.13022. Epub 2021 Jun 15.
PMID: 34053182BACKGROUNDPaltrinieri S, Fugazzaro S, Bertozzi L, Bassi MC, Pellegrini M, Vicentini M, Mazzini E, Costi S. Return to work in European Cancer survivors: a systematic review. Support Care Cancer. 2018 Sep;26(9):2983-2994. doi: 10.1007/s00520-018-4270-6. Epub 2018 May 29.
PMID: 29845421BACKGROUNDde Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, Miglioretti M, Munir F, Popa AE, Sedlakova M, Torp S, Yagil D, Tamminga S, de Boer A. The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health. J Cancer Surviv. 2020 Apr;14(2):188-199. doi: 10.1007/s11764-019-00829-y. Epub 2019 Nov 22.
PMID: 31758518BACKGROUNDTiedtke CM, Dierckx de Casterle B, Frings-Dresen MHW, De Boer AGEM, Greidanus MA, Tamminga SJ, De Rijk AE. Employers' experience of employees with cancer: trajectories of complex communication. J Cancer Surviv. 2017 Oct;11(5):562-577. doi: 10.1007/s11764-017-0626-z. Epub 2017 Jul 14.
PMID: 28710544BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Paltrinieri, PhD, OT
Azienda USL - IRCCS di Reggio Emilia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 29, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share